Skip to main content
. 2020 Apr 1;16(6):1299–1305. doi: 10.1080/21645515.2020.1733868

Figure 2.

Figure 2.

Proportion of participants with rSBA titers ≥1:128 at (a) baseline and (b) Day 30 (PPAS).